These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22191103)

  • 21. Mass drug administration to eliminate lymphatic filariasis in India.
    Ramaiah KD; Das PK
    Trends Parasitol; 2004 Nov; 20(11):499-502. PubMed ID: 15471698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme.
    Mohammed KA; Molyneux DH; Albonico M; Rio F
    Trends Parasitol; 2006 Jul; 22(7):340-4. PubMed ID: 16713740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphatic filariasis.
    Wkly Epidemiol Rec; 2002 Apr; 77(16):125-32. PubMed ID: 12004537
    [No Abstract]   [Full Text] [Related]  

  • 24. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2008 Sep; 83(37):333-41. PubMed ID: 18788146
    [No Abstract]   [Full Text] [Related]  

  • 25. The end of lymphatic filariasis?
    Bockarie MJ; Molyneux DH
    BMJ; 2009 May; 338():b1686. PubMed ID: 19439451
    [No Abstract]   [Full Text] [Related]  

  • 26. Meeting of the International Task Force for Disease Eradication – November 2012.
    Wkly Epidemiol Rec; 2013 Feb; 88(7):75-80. PubMed ID: 23540049
    [No Abstract]   [Full Text] [Related]  

  • 27. Informal consultation on preventing disability from lymphatic filariasis, WHO, Geneva, August 2006.
    Wkly Epidemiol Rec; 2006 Oct; 81(40):373-83. PubMed ID: 17031901
    [No Abstract]   [Full Text] [Related]  

  • 28. Elimination of lymphatic filariasis: a public-health challenge.
    Zagaria N; Savioli L
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S3-13. PubMed ID: 12630389
    [No Abstract]   [Full Text] [Related]  

  • 29. Global programme to eliminate lymphatic filariasis: progress report, 2013.
    Wkly Epidemiol Rec; 2014 Sep; 89(38):409-18. PubMed ID: 25243263
    [No Abstract]   [Full Text] [Related]  

  • 30. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
    Nandha B; Krishnamoorthy K; Jambulingam P
    Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing the population requiring interventions against lymphatic filariasis in Africa.
    Bockarie MJ; Rebollo MP
    Lancet Glob Health; 2016 Mar; 4(3):e154-5. PubMed ID: 26874545
    [No Abstract]   [Full Text] [Related]  

  • 32. Healthcare workers' knowledge of lymphatic filariasis and its control in an endemic area of Eastern India: implications on control programme.
    Babu BV; Satyanarayana K
    Trop Doct; 2003 Jan; 33(1):41-2. PubMed ID: 12568522
    [No Abstract]   [Full Text] [Related]  

  • 33. The programme to eliminate lymphatic filariasis in Orissa, India: the attitudes of some programme partners.
    Babu BV; Nath N
    Ann Trop Med Parasitol; 2004 Oct; 98(7):751-7. PubMed ID: 15509429
    [No Abstract]   [Full Text] [Related]  

  • 34. Lymphatic filariasis elimination: progress in global programme development.
    Molyneux DH; Zagaria N
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S15-40. PubMed ID: 12630391
    [No Abstract]   [Full Text] [Related]  

  • 35. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
    Hooper PJ; Bradley MH; Biswas G; Ottesen EA
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventing confusion about side effects in a campaign to eliminate lymphatic filariasis.
    Ramaiah KD; Ravi R; Das PK
    Trends Parasitol; 2005 Jul; 21(7):307-8. PubMed ID: 15923141
    [No Abstract]   [Full Text] [Related]  

  • 37. Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis.
    Brantus P
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S5-10. PubMed ID: 19843392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge and beliefs about elephantiasis and hydrocele of lymphatic filariasis and some socio-demographic determinants in an endemic community of Eastern India.
    Babu BV; Hazra RK; Chhotray GP; Satyanarayana K
    Public Health; 2004 Mar; 118(2):121-7. PubMed ID: 15037042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphatic filariasis in India: epidemiology and control measures.
    Raju K; Jambulingam P; Sabesan S; Vanamail P
    J Postgrad Med; 2010; 56(3):232-8. PubMed ID: 20739779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis.
    Ramaiah KD; Vijay Kumar KN; Ravi R; Das PK
    Ann Trop Med Parasitol; 2005 Apr; 99(3):243-52. PubMed ID: 15829134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.